Literature DB >> 26674330

Recognizing and preventing epilepsy-related mortality: A call for action.

Orrin Devinsky1, Tanya Spruill2, David Thurman2, Daniel Friedman2.   

Abstract

Epilepsy is associated with a high rate of premature mortality from direct and indirect effects of seizures, epilepsy, and antiseizure therapies. Sudden unexpected death in epilepsy (SUDEP) is the second leading neurologic cause of total lost potential life-years after stroke, yet SUDEP may account for less than half of all epilepsy-related deaths. Some epilepsy groups are especially vulnerable: individuals from low socioeconomic status groups and those with comorbid psychiatric illness die more often than controls. Despite clear evidence of an important public health problem, efforts to assess and prevent epilepsy-related deaths remain inadequate. We discuss factors contributing to the underestimation of SUDEP and other epilepsy-related causes of death. We suggest the need for a systematic classification of deaths directly due to epilepsy (e.g., SUDEP, drowning), due to acute symptomatic seizures, and indirectly due to epilepsy (e.g., suicide, chronic effects of antiseizure medications). Accurately estimating the frequency of epilepsy-related mortality is essential to support the development and assessment of preventive interventions. We propose that educational interventions and public health campaigns targeting medication adherence, psychiatric comorbidity, and other modifiable risk factors may reduce epilepsy-related mortality. Educational campaigns regarding sudden infant death syndrome and fires, which kill far fewer Americans than epilepsy, have been widely implemented. We have done too little to prevent epilepsy-related deaths. Everyone with epilepsy and everyone who treats people with epilepsy need to know that controlling seizures will save lives.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26674330      PMCID: PMC4763802          DOI: 10.1212/WNL.0000000000002253

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  54 in total

1.  Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials.

Authors:  Philippe Ryvlin; Michel Cucherat; Sylvain Rheims
Journal:  Lancet Neurol       Date:  2011-09-19       Impact factor: 44.182

2.  Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.

Authors:  Alice Dragomir; Robert Côté; Louise Roy; Lucie Blais; Lyne Lalonde; Anick Bérard; Sylvie Perreault
Journal:  Med Care       Date:  2010-05       Impact factor: 2.983

3.  Sudden unexpected death in epilepsy: knowledge and experience among U.S. and Canadian neurologists.

Authors:  Daniel Friedman; Elizabeth J Donner; Derek Stephens; Cyndi Wright; Orrin Devinsky
Journal:  Epilepsy Behav       Date:  2014-05-03       Impact factor: 2.937

4.  Characteristics of epilepsy patients and caregivers who either have or have not heard of SUDEP.

Authors:  Barbara L Kroner; Cyndi Wright; Daniel Friedman; Kim Macher; Liliana Preiss; Jade Misajon; Orrin Devinsky
Journal:  Epilepsia       Date:  2014-10-16       Impact factor: 5.864

Review 5.  Metabolic consequences of antiepileptic drugs.

Authors:  Scott Mintzer
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

6.  Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy.

Authors:  J G Burneo; L Black; R C Knowlton; E Faught; R Morawetz; R I Kuzniecky
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

7.  Age trends in autopsy rates. Striking decline in late life.

Authors:  J C Ahronheim; A S Bernholc; W D Clark
Journal:  JAMA       Date:  1983-09-02       Impact factor: 56.272

8.  Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study.

Authors:  Anders Gaarsdal Holst; Bo Gregers Winkel; Bjarke Risgaard; Jonas Bille Nielsen; Peter Vibe Rasmussen; Stig Haunsø; Anne Sabers; Peter Uldall; Jacob Tfelt-Hansen
Journal:  Epilepsia       Date:  2013-07-29       Impact factor: 5.864

9.  Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring.

Authors:  A L Rabinowicz; J Correale; R B Boutros; W T Couldwell; C W Henderson; C M DeGiorgio
Journal:  Epilepsia       Date:  1996-02       Impact factor: 5.864

10.  Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study.

Authors:  Claudia A Granbichler; Willi Oberaigner; Giorgi Kuchukhidze; Gerhard Bauer; Jean-Pierre Ndayisaba; Klaus Seppi; Eugen Trinka
Journal:  J Neurol       Date:  2014-10-26       Impact factor: 4.849

View more
  29 in total

1.  Progress in defining autonomic consequences of seizure activity including sudden death.

Authors:  Mark Stewart
Journal:  Clin Auton Res       Date:  2019-01-25       Impact factor: 4.435

Review 2.  [Sudden unexpected death in epilepsy (SUDEP) : Epidemiology, cardiac and other risk factors].

Authors:  Theodor W May; Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-09

Review 3.  National Association of Medical Examiners position paper: Recommendations for the investigation and certification of deaths in people with epilepsy.

Authors:  Owen Middleton; Daniel Atherton; Elizabeth Bundock; Elizabeth Donner; Daniel Friedman; Dale Hesdorffer; Heather Jarrell; Aileen McCrillis; Othon J Mena; Mitchel Morey; David Thurman; Niu Tian; Torbjörn Tomson; Zian Tseng; Steven White; Cyndi Wright; Orrin Devinsky
Journal:  Epilepsia       Date:  2018-03-01       Impact factor: 5.864

4.  QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality.

Authors:  C Anwar A Chahal; Joseph A Gottwald; Erik K St Louis; Jiang Xie; Peter A Brady; Rabe E Alhurani; Paul Timm; Prabin Thapa; Jay Mandrekar; Elson L So; Janet E Olson; Michael J Ackerman; Virend K Somers
Journal:  Heart Rhythm       Date:  2021-11-11       Impact factor: 6.343

5.  Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice.

Authors:  Melissa L Barker-Haliski; Fabiola Vanegas; Matthew J Mau; Tristan K Underwood; H Steve White
Journal:  Epilepsia       Date:  2016-07-28       Impact factor: 5.864

Review 6.  Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability.

Authors:  Phan Q Duy; Miao He; Zhigang He; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-05-05       Impact factor: 6.902

Review 7.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

8.  Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.

Authors:  Aristea S Galanopoulou; Wolfgang Löscher; Laura Lubbers; Terence J O'Brien; Kevin Staley; Annamaria Vezzani; Raimondo D'Ambrosio; H Steve White; Harald Sontheimer; John A Wolf; Roy Twyman; Vicky Whittemore; Karen S Wilcox; Brian Klein
Journal:  Epilepsia Open       Date:  2021-05-06

9.  Probable Sudden Unexpected Death in Dogs With Epilepsy (pSUDED).

Authors:  Enrice Huenerfauth; Jasmin Nessler; Johannes Erath; Andrea Tipold
Journal:  Front Vet Sci       Date:  2021-04-27

10.  Risk of Unnatural Mortality in People With Epilepsy.

Authors:  Hayley C Gorton; Roger T Webb; Matthew J Carr; Marcos DelPozo-Banos; Ann John; Darren M Ashcroft
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.